title: Magnetic resonance imaging in assessment of rejection of a kidney allograft in the rat: effect of the somatostatin analogue SMS 201-995.
authors.affiliation: Sandoz Pharma Ltd., Basel, Switzerland.
authors.forename: H J
authors.initials: HJ
authors.lastname: Schuurman
authors.forename: N
authors.initials: N
authors.lastname: Beckmann
authors.forename: U
authors.initials: U
authors.lastname: Briner
authors.forename: C
authors.initials: C
authors.lastname: Bruns
authors.forename: K
authors.initials: K
authors.lastname: Bruttel
authors.forename: M
authors.initials: M
authors.lastname: Tanner
authors.forename: L
authors.initials: L
authors.lastname: Tolcsvai
authors.forename: G
authors.initials: G
authors.lastname: Weckbecker
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D008279:Magnetic Resonance Imaging; D008297:Male; D015282:Octreotide / Q000493:pharmacokinetics / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D012079:Renal Circulation / Q000187:drug effects; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D015282:Octreotide